Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis
Hormone and Metabolic Research · 01.08.2024 · 56 (08) · 593-603
DOI: 10.1055/a-2209-0771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.08.2024. Verfasst von Jian-Bin Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Third Clinical Medical College, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Computational Biology, Adrenal Cortex Neoplasms, Protein Interaction Maps. Die Arbeit nennt 85 Literaturangaben.
Abstract (Originalsprache)
Adrenocortical carcinoma (ACC) is a malignant carcinoma with an extremely poor prognosis, and its pathogenesis remains to be understood to date, necessitating further investigation. This study aims to discover biomarkers and potential therapeutic agents for ACC through bioinformatics, enhancing clinical diagnosis and treatment strategies. Differentially expressed genes (DEGs) between ACC and normal adrenal cortex were screened out from the GSE19750 and GSE90713 datasets available in the GEO database. An online Venn diagram tool was utilized to identify the common DEGs between the two datasets. The identified DEGs were subjected to functional assessment, pathway enrichment, and identification of hub genes by performing the protein-protein interaction (PPI), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The differences in the expressions of hub genes between ACC and normal adrenal cortex were validated at the GEPIA2 website, and the association of these genes with the overall patient survival was also assessed. Finally, on the QuartataWeb website, drugs related to the identified hub genes were determined. A total of 114 DEGs, 10 hub genes, and 69 known drugs that could interact with these genes were identified. The GO and KEGG analyses revealed a close association of the identified DEGs with cellular signal transduction. The 10 hub genes identified were overexpressed in ACC, in addition to being significantly associated with adverse prognosis in ACC. Three genes and the associated known drugs were identified as potential targets for ACC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Third Clinical Medical College, Fujian Medical University, Fuzhou, China.
- Department of Endocrinology, Zhongshan Hospital Xiamen University, Xiamen, China.
ORCID-Profile: Jian-Bin Wei
Zitieren
APA
Wei, J. B., Zeng, X. C., Ji, K. R., Zhang, L. Y., & Chen, X. M. (2024). Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis. Hormone and Metabolic Research, 56(08), 593-603. https://doi.org/10.1055/a-2209-0771
Vancouver
Wei JB, Zeng XC, Ji KR, Zhang LY, Chen XM. Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis. Hormone and Metabolic Research. 2024;56(08):593-603. doi:10.1055/a-2209-0771
BibTeX
@article{Wei2024,
author = {Wei, Jian-Bin and Zeng, Xiao-Chun and Ji, Kui-Rong and Zhang, Ling-Yi and Chen, Xiao-Min},
title = {Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {08},
pages = {593--603},
doi = {10.1055/a-2209-0771}
}
EUVIMED